Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Infect Immun
2003 Jan 01;711:132-9. doi: 10.1128/IAI.71.1.132-139.2003.
Show Gene links
Show Anatomy links
The hyaluronic acid capsule of Streptococcus uberis is not required for the development of infection and clinical mastitis.
Field TR
,
Ward PN
,
Pedersen LH
,
Leigh JA
.
???displayArticle.abstract???
The frequency at which the genes responsible for capsule biosynthesis occurred in field isolates of Streptococcus uberis was determined. Of the two genotypes detected (hasABC and hasC), the capsular genotype (hasABC) was more common. This genotype was present at a higher frequency in a population isolated from mastitis cases than in a population isolated from cattle bedding. The virulence of a mutant strain of S. uberis (TRF0-6) that lacked the ability to produce a hyaluronic acid capsule due to an insertion within its single copy of hasA (P. N. Ward, T. R. Field, W. G. F. Ditcham, E. Maguin, and J. A. Leigh, Infect. Immun. 69:392-399, 2001) was compared to that of the capsular parental strain (0140J). Strains TRF0-6 and 0140J infected all mammary gland quarters following experimental challenge. The wild type and the mutant induced overt signs of disease in four out of four and in six out of eight mammary gland quarters, respectively. Both the wild type and the hasA mutant were resistant to killing by bovine neutrophils following cultivation in bovine milk. The ability to withstand the bactericidal action of neutrophils following growth in milk was therefore independent of the capsule and coincided with the ability of supernatants from such cultures to prevent the bactericidal action of neutrophils. This investigation revealed that, in the absence of the capsule, S. uberis is able to withstand the bactericidal effect of bovine neutrophils and induce mastitis in dairy cows.
Almeida,
Growth curve, capsule expression and characterization of the capsular material of selected strains of Streptococcus uberis.
1993, Pubmed
Almeida,
Growth curve, capsule expression and characterization of the capsular material of selected strains of Streptococcus uberis.
1993,
Pubmed
Almeida,
Antiphagocytic effect of the capsule of Streptococcus uberis.
1993,
Pubmed
Dale,
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
1996,
Pubmed
Field,
Changes in bovine neutrophils induced by the capsule of Streptococcus uberis.
1997,
Pubmed
Finch,
Further studies on the efficacy of a live vaccine against mastitis caused by Streptococcus uberis.
1997,
Pubmed
Finch,
Local vaccination with killed Streptococcus uberis protects the bovine mammary gland against experimental intramammary challenge with the homologous strain.
1994,
Pubmed
Giegerich,
GeneFisher--software support for the detection of postulated genes.
1996,
Pubmed
Hassan,
Evaluation of PCR methods for rapid identification and differentiation of Streptococcus uberis and Streptococcus parauberis.
2001,
Pubmed
Hill,
The elimination of serum-resistant Escherichia coli from experimentally infected single mammary glands of healthy cows.
1978,
Pubmed
Hill,
Increase in specific opsonic activity in bovine milk following experimental Escherichia coli mastitis.
1983,
Pubmed
Hill,
Protective effect of previous intramammary infection with Streptococcus uberis against subsequent clinical mastitis in the cow.
1988,
Pubmed
Hill,
Pathogenicity of two strains of Streptococcus uberis infused into lactating and non-lactating bovine mammary glands.
1988,
Pubmed
Hill,
DNA fingerprinting of Streptococcus uberis: a useful tool for epidemiology of bovine mastitis.
1989,
Pubmed
Hill,
Immune modification of the pathogenesis of Streptococcus uberis mastitis in the dairy cow.
1994,
Pubmed
Hillerton,
Effect of pre-milking teat dipping on clinical mastitis on dairy farms in England.
1993,
Pubmed
Kossaibati,
The costs of production diseases in dairy herds in England.
1997,
Pubmed
Leigh,
Two strains of Streptococcus uberis, of differing ability to cause clinical mastitis, differ in their ability to resist some host defence factors.
1990,
Pubmed
Leigh,
Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin.
1994,
Pubmed
Leigh,
Vaccination with the plasminogen activator from Streptococcus uberis induces an inhibitory response and protects against experimental infection in the dairy cow.
1999,
Pubmed
Moses,
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus.
1997,
Pubmed
Paape,
Phagocytic defense of the ruminant mammary gland.
1981,
Pubmed
Persson,
Effects of certain inflammatory mediators on bovine neutrophil migration in vivo and in vitro.
1993,
Pubmed
Schalm,
Conversion of chronic staphylococcal mastitis to acute gangrenous mastitis after neutropenia in blood and bone marrow produced by an equine anti-bovine leukocyte serum.
1976,
Pubmed
Thomas,
Pathologic findings of experimentally induced Streptococcus uberis infection in the mammary gland of cows.
1994,
Pubmed
Ward,
Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis.
2001,
Pubmed
Watts,
Etiological agents of bovine mastitis.
1988,
Pubmed
Williams,
A role for IgM in the in vitro opsonisation of Staphylococcus aureus and Escherichia coli by bovine polymorphonuclear leucocytes.
1982,
Pubmed
